NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Immune cell therapies and immune cell engineering

Original research

NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome

Online download statistics by month:

Online download statistics by month: June 2022 to August 2023

	Abstract	Full	Pdf
Jun 2022	218	218	43
Jul 2022	916	942	271
Aug 2022	498	520	123
Sep 2022	396	412	143
Oct 2022	357	376	119
Nov 2022	337	338	106
Dec 2022	234	236	87
Jan 2023	303	316	112
Feb 2023	295	302	120
Mar 2023	256	257	103
Apr 2023	207	210	98
May 2023	225	228	108
Jun 2023	171	174	62
Jul 2023	211	216	74
Aug 2023	188	190	68
Total	4812	4935	1637